IL63627A - Phen(alk)oxy-substituted oxiranecarboxylic acids,processes for their preparation and pharmaceutical preparations containing them - Google Patents

Phen(alk)oxy-substituted oxiranecarboxylic acids,processes for their preparation and pharmaceutical preparations containing them

Info

Publication number
IL63627A
IL63627A IL63627A IL6362781A IL63627A IL 63627 A IL63627 A IL 63627A IL 63627 A IL63627 A IL 63627A IL 6362781 A IL6362781 A IL 6362781A IL 63627 A IL63627 A IL 63627A
Authority
IL
Israel
Prior art keywords
phen
alk
oxy
processes
preparation
Prior art date
Application number
IL63627A
Other languages
English (en)
Other versions
IL63627A0 (en
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of IL63627A0 publication Critical patent/IL63627A0/xx
Publication of IL63627A publication Critical patent/IL63627A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL63627A 1980-08-25 1981-08-20 Phen(alk)oxy-substituted oxiranecarboxylic acids,processes for their preparation and pharmaceutical preparations containing them IL63627A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH639780 1980-08-25
CH152681 1981-03-06

Publications (2)

Publication Number Publication Date
IL63627A0 IL63627A0 (en) 1981-11-30
IL63627A true IL63627A (en) 1984-11-30

Family

ID=25687902

Family Applications (1)

Application Number Title Priority Date Filing Date
IL63627A IL63627A (en) 1980-08-25 1981-08-20 Phen(alk)oxy-substituted oxiranecarboxylic acids,processes for their preparation and pharmaceutical preparations containing them

Country Status (16)

Country Link
US (1) US4337267A (xx)
EP (1) EP0046590B1 (xx)
JP (1) JPS6059914B2 (xx)
AU (1) AU549447B2 (xx)
CA (1) CA1167050A (xx)
DE (1) DE3170608D1 (xx)
DK (1) DK171890B1 (xx)
ES (1) ES504922A0 (xx)
GR (1) GR75741B (xx)
IE (1) IE51534B1 (xx)
IL (1) IL63627A (xx)
NZ (1) NZ198136A (xx)
PH (1) PH21847A (xx)
PT (1) PT73563B (xx)
WO (1) WO1982000643A1 (xx)
YU (1) YU206681A (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3680507D1 (de) * 1985-08-02 1991-08-29 Byk Gulden Lomberg Chem Fab Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie.
GB2202222B (en) * 1987-03-16 1991-03-27 American Home Prod Fluorooxirane carboxylates
US4788304A (en) * 1987-12-07 1988-11-29 American Home Products Corporation Phospholipase A2 inhibitors
DE3906953A1 (de) * 1989-03-04 1990-09-20 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung optisch reiner oxirancarbonsaeuren
US5545672A (en) * 1993-02-11 1996-08-13 The University Of Texas System Treatment of insulin resistance and type 2 diabetes mellitus with a thiol protease inhibitor
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
AU3464397A (en) * 1996-07-02 1998-01-21 Sang Sup Jew Oxirane carboxylic acid derivative and its manufacturing method
KR19980028082A (ko) * 1996-10-21 1998-07-15 김박광 혈당 강하 작용을 갖는 신규 옥시란 카복실산의 유도체, 그 제조방법 및 이를 함유하는 당뇨병 치료제
DE19705718A1 (de) 1997-02-14 1998-08-20 Horst P O Dr Wolf Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände
US5932763A (en) * 1997-05-15 1999-08-03 Bayer Corporation Inhibition of matrix metalloproteases by 2-(ω-arolalkyl)-4-biaryl-4-oxobutyric acids
DE10115938A1 (de) * 2001-03-30 2002-10-10 Medigene Ag Ges Fuer Molekular Verfahren zur Herstellung von Oxirancarbonsäuren und Derivaten davon
WO2003026582A2 (en) * 2001-09-26 2003-04-03 Emisphere Technologies Inc. Method of preparing phenoxy alkanoic, alkenoic, and alkynoic acids and salts thereof via a dicarboxylate intermediate
AU2004212004B2 (en) * 2003-02-13 2008-01-10 Albert Einstein College Of Medicine Of Yeshiva University Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus
WO2006041922A2 (en) * 2004-10-08 2006-04-20 Dara Biosciences, Inc. Agents and methods for administration to the central nervous system
WO2006088875A2 (en) * 2005-02-14 2006-08-24 Albert Einstein College Of Medicine Of Yeshiva University Intranasal administration of modulators of hypothalamic atp-sensitive potassium channels
CA2766282C (en) * 2008-06-27 2021-03-02 Meta-Iq Aps Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
EP3307262B1 (en) 2015-06-15 2021-05-19 NMD Pharma A/S Compounds for use in treating neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1551078A (en) * 1975-09-22 1979-08-22 Mcneilab Inc Alkyl-substituted glycidates and thioglycidates
US4196300A (en) * 1975-09-22 1980-04-01 Mcneilabs, Inc. α-Alkyl-substituted glycidates and thioglycidates
US4132720A (en) * 1978-04-20 1979-01-02 Mcneil Laboratories, Inc. Alkenylglycidic acid derivatives
US4132719A (en) * 1978-04-20 1979-01-02 Mcneilab Inc. Dibromoalkylglycidic acid derivatives
ATE3291T1 (de) * 1979-09-07 1983-05-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituierte oxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel.

Also Published As

Publication number Publication date
AU7447581A (en) 1982-03-04
WO1982000643A1 (en) 1982-03-04
IL63627A0 (en) 1981-11-30
ES8300730A1 (es) 1982-11-16
IE51534B1 (en) 1987-01-07
PH21847A (en) 1988-03-17
PT73563B (en) 1983-07-14
AU549447B2 (en) 1986-01-30
JPS6059914B2 (ja) 1985-12-27
DE3170608D1 (en) 1985-06-27
CA1167050A (en) 1984-05-08
EP0046590A2 (de) 1982-03-03
EP0046590A3 (en) 1982-04-07
IE811931L (en) 1982-02-25
NZ198136A (en) 1983-12-16
EP0046590B1 (de) 1985-05-22
JPS57501233A (xx) 1982-07-15
YU206681A (en) 1983-10-31
ES504922A0 (es) 1982-11-16
US4337267A (en) 1982-06-29
DK183882A (da) 1982-04-23
PT73563A (en) 1981-09-01
GR75741B (xx) 1984-08-02
DK171890B1 (da) 1997-08-04

Similar Documents

Publication Publication Date Title
IL63627A0 (en) Phen(alk)oxy-substituted oxiranecarboxylic acids,processes for their preparation and pharmaceutical preparations containing them
DE3266354D1 (en) Possibly protected peptides, process for their preparation and pharmaceutical agents containing them
DE3166619D1 (en) 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids, process for their preparation and pharmaceutical compositions containing them
IL67763A0 (en) Diphosphonic acid derivatives,process for their preparation and pharmaceutical preparations containing them
GB8313530D0 (en) Pharmaceutical preparations
ZA82433B (en) Phosphoryl compounds,pharmaceutical preparations containing such compounds,and their use
GB8321595D0 (en) Pharmaceutical preparations
IL83357A (en) Renin-inhibiting peptides, process for their preparation, pharmaceutical compositions containing them, and their use
ZA821957B (en) Acylquinolinone derivatives, processes for their manufacture, pharmaceutical preparations containing them and their use
IL65247A0 (en) Amido-amino acids,process for their preparation and pharmaceutical compositions containing them
AU542157B2 (en) Epoxycycloalkylalkanecarboxylic acids, processes for their preparation, their use and medicaments containing them
IL69164A0 (en) Diphosphonic acid derivatives,processes for the manufacture thereof and pharmaceutical preparations containing the same
GB2073747B (en) Triazolopyridinone compounds process for the preparation thereof and pharmaceutical preparations containing them
GB2106109B (en) Novel polycyclic polyazaheterocycles, processes for their manufacture and pharmaceutical preparations containing them
DE3070278D1 (en) Peptides, processes for their preparation and pharmaceutical compositions containing them
PT77657A (en) Processes for preparing novel heterocyclyl compounds and pharmaceutical preparations containing these compounds
ZA815684B (en) Novel diaryl-imidazole compounds,processes for their manufacture,pharmaceutical preparations containing these compounds,and their use
IL65541A0 (en) Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same
ZA83567B (en) Diphosphonic acid derivatives, process for their preparation and pharmaceutical preparation containing them
DE3174158D1 (en) New peptide, process for preparation thereof and pharmaceutical composition containing it
DE3160290D1 (en) Hypoglycemic guanylamidines, processes for their preparation, and pharmaceutical compositions containing them
ZA815621B (en) Novel polyazaheterocyclic compounds,process for their manufacture and pharmaceutical preparations containing them
DE3264212D1 (en) Phosphorus-containing oligopeptides, processes for preparation thereof and a pharmaceutical composition containing the same
DE3172076D1 (en) New peptide, process for preparation thereof and use thereof
ZA815832B (en) Phen(alk)oxy-substituted oxiranecarboxylic acids,processes for their preparation,their use and medicaments containing these compounds

Legal Events

Date Code Title Description
KB Patent renewed
EXP Patent expired